title: Letter: what else can improve survival in cirrhotic patients with spontaneous bacterial peritonitis and associated septic shock? Authors' reply.
authors.affiliation: Division of Critical Care Medicine and Gastroenterology/Hepatology, University of Alberta, Edmonton, AB, Canada. dean.karvellas@ualberta.ca.|Division of Gastroenterology and Hepatology, University of Alberta, Edmonton, AB, Canada. dean.karvellas@ualberta.ca.
authors.forename: C J
authors.initials: CJ
authors.lastname: Karvellas
authors.affiliation: Division of Gastroenterology and Hepatology, University of Alberta, Edmonton, AB, Canada.
authors.forename: J G
authors.initials: JG
authors.lastname: Abraldes
authors.affiliation: Intensive Care Department, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.
authors.forename: Y
authors.initials: Y
authors.lastname: Arabi
authors.affiliation: Section of Critical Care Medicine and Section of Infectious Diseases, Health Sciences Center and St. Boniface Hospital, University of Manitoba, Winnipeg, MB Canada.
authors.forename: A
authors.initials: A
authors.lastname: Kumar
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D010538:Peritonitis / Q000188:drug therapy*; D012772:Shock, Septic / Q000188:drug therapy*
chemical_list: D000890:Anti-Infective Agents